Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion (original) (raw)
References
Blomqvist, C., Sarna, S. & Elomaa, I. et al ( (1996) Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer73: 1074–1079. ArticleCAS Google Scholar
Blumsohn, A., Naylor, R. A. & Eastell, R. et al ( (1994) The effects of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endoc Metab79: 730–735. CAS Google Scholar
Bonde, M., Qvist, P. & Christiansen, C. et al ( (1995) Applications of an enzyme immunoassay for a new marker of bone resorption (Crosslaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab80: 864–868. CASPubMed Google Scholar
Campbell, F. C., Blamey, R. W., Woolfson, A. M. J., Elston, C. W. & Hosking, D. T. (1983) Calcium excretion CaE in metastatic breast cancer. Br J Surg70: 202–204. ArticleCAS Google Scholar
Coleman, R. E. (1994) Evaluation of bone disease in breast cancer. Breast3: 73–78. Article Google Scholar
Coleman, R. E. (1999) Monitoring of bone metastases. Eur J Cancer34: 252–259. Article Google Scholar
Coleman, R. E. & Rubens, R. D. (1985) Bone metastases and breast cancer. Cancer Treat Rev12: 251–270. ArticleCAS Google Scholar
Coleman, R. E., Whitaker, K. B., Moss, D. W., Mashiter, G., Fogelman, I. & Rubens, R. D. (1988) Biochemical prediction of response of bone metastases to treatment. Br J Cancer58: 205–210. ArticleCAS Google Scholar
Downey, S., Eastell, R. & Howell, A. et al ( (1994) Pyridinoline excretion can monitor bone metastases in breast cancer. Breast Cancer Res Treat32: 83 Google Scholar
Galasko, C. S. B. (1994). Diagnosis of skeletal metastases and assessment of response to treatment. In Metastatic Bone Disease, Diel IJ, Kaufmann M and Bastert G (eds), pp. 93–107. Springer Verlag: Heidelberg Chapter Google Scholar
Hanson, D., Weis, M. A. E. & Bollen, A. M. et al ( (1992) A specific immunoassay for monitoring human bone resorption: quantification of type 1 collagen cross-linked N-telopeptides in urine. J Bone Miner Res7: 1251–1258. ArticleCAS Google Scholar
Hayward, J. L., Carbone, P. P., Heuson, J. C., Kumaoka, S., Segaloff, A. & Rubens, R. D. (1977) Assessment of response to therapy in advanced breast cancer. Cancer3: 1389–1394. Google Scholar
Howell, A., Mackintosh, J., Jones, M., Radford, J., Wagstaff, J. & Selwood, R. A. (1988) The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for 6 advanced carcinoma of the breast. Eur J Cancer24: 1567–1572. ArticleCAS Google Scholar
Lipton, A., Hortobagyi, G. & Reitsma, D. et al ( (1995) Markers of bone resorption in patients treated with pamidronate. Bone17: 615 Article Google Scholar
Robertson, J. F. R., Pearson, D., Price, M. R., Selby, C., Blamey, R. & Howell, A. (1991) Objective assessment of therapeutic response in breast cancer using tumour markers. Br J Cancer64: 757–763. ArticleCAS Google Scholar
Vinholes, J. J., Guo, C-Y, Purohit, O. P., Eastell, R. & Coleman, R. E. (1996) Metabolic effects of pamidronate in patients with metastatic bone disease. Br J Cancer73: 1089–1095. ArticleCAS Google Scholar
Vinholes, J., Guo, C-Y, Purohit, O. P., Eastell, R. & Coleman, R. E. (1997a) Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcaemia of malignancy. J Clin Oncol15: 131–138. ArticleCAS Google Scholar
Vinholes, J., Purohit, O. P., Abbey, M. E., Eastell, R. & Coleman, R. (1997b) Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease. Ann Oncol8: 1243–1250. ArticleCAS Google Scholar